In the same investigation, in the CSF of cognitively normal “at-risk” subjects with a parental history of late-onset AD, PCSK9 levels appeared to positively and significantly correlate with ApoE, total tau, and phosphorylated tau levels, but not with those of Aβ42 [124]. This evidence concerns the gene PCSK9 and Alzheimer disease.